Literature DB >> 11444092

The burden of osteoporotic fractures: a method for setting intervention thresholds.

J A Kanis1, A Oden, O Johnell, B Jonsson, C de Laet, A Dawson.   

Abstract

The aim of this study was to assess the relationship between morbidity from hip fracture and that from other osteoporotic fractures by age and sex based on the population of Sweden. Osteoporotic fractures were designated as those associated with low bone mineral density (BMD) and those that increased in incidence with age after the age of 50 years. Severity of fractures was weighted according to their morbidity using utility values based on those derived by the National Osteoporosis Foundation. Morbidity from fractures other than hip fracture was converted to hip fracture equivalents according to their disutility weights. Excess morbidity was 3.34 and 4.75 in men and women at the age of 50 years, i.e. the morbidity associated with osteoporotic fractures was 3-5 times that accounted for by hip fracture. Excess morbidity decreased with age to approximately 1.25 between the ages of 85 and 89 years. On the assumption that the age- and sex-specific pattern of fractures due to osteoporosis is similar in different communities, the computation of excess morbidity can be utilized to determine the total morbidity from osteoporotic fractures from knowledge of hip fracture rates alone. Such data can be used to weight probabilities of hip fracture in different countries in order to take into account the morbidity from fractures other than hip fracture, and to modify intervention thresholds based on hip fracture risk alone. If, for example, a 10-year probability of hip fracture of 10% was considered an intervention threshold, this would be exceeded in women with osteoporosis aged 65 years and more, but when weighted for other osteoporotic fractures would be exceeded in all women (and men) with osteoporosis.

Entities:  

Mesh:

Year:  2001        PMID: 11444092     DOI: 10.1007/s001980170112

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  227 in total

1.  Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective.

Authors:  F Borgström; O Ström; M Kleman; E McCloskey; H Johansson; A Odén; J A Kanis
Journal:  Osteoporos Int       Date:  2010-06-08       Impact factor: 4.507

Review 2.  Bone Density Screening and Re-screening in Postmenopausal Women and Older Men.

Authors:  Margaret L Gourlay; Robert A Overman; Kristine E Ensrud
Journal:  Curr Osteoporos Rep       Date:  2015-12       Impact factor: 5.096

3.  Ten-year prediction of osteoporosis from baseline bone mineral density: development of prognostic thresholds in healthy postmenopausal women. The Danish Osteoporosis Prevention Study.

Authors:  Bo Abrahamsen; Lars Rejnmark; Stig Pors Nielsen; Bo Rud; Nis Nissen; Leif Mosekilde; Olaf Bärenholdt; Jens-Erik Beck Jensen
Journal:  Osteoporos Int       Date:  2005-09-10       Impact factor: 4.507

4.  Institutionalization following incident non-traumatic fractures in community-dwelling men and women.

Authors:  S Morin; L M Lix; M Azimaee; C Metge; S R Majumdar; W D Leslie
Journal:  Osteoporos Int       Date:  2011-10-19       Impact factor: 4.507

5.  The risk and burden of vertebral fractures in Sweden.

Authors:  J A Kanis; O Johnell; A Oden; F Borgstrom; N Zethraeus; C De Laet; B Jonsson
Journal:  Osteoporos Int       Date:  2003-10-31       Impact factor: 4.507

6.  The effect of vigorous physical activity and risk of wrist fracture over 25 years in a low-risk survivor cohort.

Authors:  Donna L Thorpe; Synnove F Knutsen; W Lawrence Beeson; Gary E Fraser
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

7.  Cost-equivalence of different osteoporotic fractures.

Authors:  L J Melton; S E Gabriel; C S Crowson; A N A Tosteson; O Johnell; J A Kanis
Journal:  Osteoporos Int       Date:  2003-04-01       Impact factor: 4.507

8.  Device-specific weighted T-score for two quantitative ultrasounds: operational propositions for the management of osteoporosis for 65 years and older women in Switzerland.

Authors:  D Hans; F Hartl; M A Krieg
Journal:  Osteoporos Int       Date:  2003-04-01       Impact factor: 4.507

9.  Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis.

Authors:  O Ström; B Jönsson; J A Kanis
Journal:  Osteoporos Int       Date:  2012-12-07       Impact factor: 4.507

10.  Bone fractures and incident epithelial ovarian cancer in a prospective cohort study.

Authors:  Kim N Danforth; Catherine Schairer; Arthur Schatzkin; James V Lacey
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.